ZLDAF

ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF)

About ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. (ZLDAF)

Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The firm engages in the research and development of cannabinoid-based formulations for the treatment of a variety of medical conditions. It focuses on human clinical trial program and pre-clinical research program. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.55
52 Week Low
$0.19
Market cap
3.6M
Dividend yield
0.00%
Volume
--
Avg. volume
4
P/E ratio
-1.06

ZELIRA THERAPEUTICS LTD by Zelira Therapeutics Ltd. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.55
52 Week Low
$0.19
Market cap
3.6M
Dividend yield
0.00%
Volume
--
Avg. volume
4
P/E ratio
-1.06